
*due to intrinsic sphincter deficiency in adult women who have SUI
or stress predominant mixed incontinence.
or stress predominant mixed incontinence.
What makes

different?

different?
How Bulkamid works
Non-particulate permanent homogenous gel.
How other bulking agents work
Particulate combination gels, where micro particles are suspended in a transient carrier liquid.


A graph showing reported success rates of women treated with Bulkamid and Contigen at 12 months4

77% of patients reported
to be cured or improved in large FDA approved RCT4
≥80% success rates reported
when Bulkamid is used as a first-line treatment option1-3
The reported success rates of women treated with Bulkamid in 3 separate studies where Bulkamid was used as a
primary procedure1-3
primary procedure1-3

Durable over time
Bulkamid has shown to maintain its efficacy at 1, 2, 5 and 7 years1,3-5
Maintained improvement in quality of life1
A graph showing ICIQ and VAS scores to 5 years following treatment with Bulkamid (n=256)

An excellent safety profile
An extremely low peri and postoperative complication rate in studies up to 7 years.
Author | Toozs-Hobson5 | Sokol4 | Pai1 | Lobodash3 | Andrews2 | Zivanovic6 | Mohr7 |
Year of publication | 2012 | 2014 | 2015 | 2015 | 2015 | 2016 | 2017 |
Number of patients | 135 | 229 | 256 | 354 | 38 | 60 | 154 |
Procedure-related serious adverse events | 0 (0%) | 1 (0.4%)* | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Acute urinary retention | 2 (1.4%) | 13 (5.7%) | 1 (0.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (1.9%) |
Acute urinary infection | 0 (0%) | 8 (3.5%) | 4 (1.6%) | 6 (1.7%) | 1 (2.6%) | 2 (3.6%) | 12 (7.8%) |
Follow up period | 24 months | 12 months | 5 years | 7 years | 6 months | 12 months | 3 months |
Author
Year of publication
Number of patients
Procedure-related serious adverse events
Acute urinary retention
Acute urinary infection
Follow up period
* Transient haematuria
The importance of patient choice
Patients want an experience that includes engagement in shared decision making 9,10.
Patient choice and involvement in decision making are becoming more important in healthcare.

did not expect a complete cure of all bladder symptoms following a SUI treatment 2

expressed a preference for minor procedures with low risk of complications and are prepared to accept a lower success rate2

would like to be told about the risks associated with each treatment option1

would like to be told how treatment options may impact their quality of life1
“Patient decision aids support conversations and help patients make informed choices”
Learn more
If you feel Bulkamid may be an option for your patients, or if you want to find out more, take a look at the following links.